3 Feb 2005 16:15
Cambridge Antibody Tech Group PLC03 February 2005 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) Name of companyCambridge Antibody Technology 2) Name of directorJohn Aston 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of anon-beneficial interest or in the case of an individual holder if it is aholding of that person's spouse or children under the age of 18 or in respect ofa non-beneficial interestAs in 2 Above 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified)Computershare Trustees Limited 5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s)As in 2 Above 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionaryAllocation of Partnership and Matching Shares under Inland Revenue ApprovedShare Incentive Plan 7) Number of shares/amount of stock acquired642 (consisting of 321 Partnership and 321 Matching Shares) 8) Percentage of issued class0.0012% 9) Number of shares/amount of stock disposedNil 10) Percentage of issued classNil 11) Class of securityOrdinary 10 pence shares 12) Price per share£4.67 13) Date of transaction3 February 2005 14) Date company informed3 February 2005 15) Total holding following this notification43,730 16) Total percentage holding of issued class following this notification0.084% If a director has been granted options by the company please complete thefollowing boxes 17) Date of grant 18) Period during which or date on which exercisable 19) Total amount paid (if any) for grant of the option 20) Description of shares or debentures involved: class, number 21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 22) Total number of shares or debentures over which options held following this notification 23) Any additional informationThis transaction is exempt pursuant to provision 20H of the Model Code of theListing Rules of the UK Listing Authority 24) Name of contact and telephone number for queriesJustin Hoskins : 01223 898589 25) Name and signature of authorised company official responsible for making this notificationDiane Mellett Date of Notification 3 February 2005 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) Name of companyCambridge Antibody Technology 2) Name of directorPeter Chambre 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of anon-beneficial interest or in the case of an individual holder if it is aholding of that person's spouse or children under the age of 18 or in respect ofa non-beneficial interestAs in 2 Above 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified)Computershare Trustees Limited 5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s)As in 2 Above 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionaryAllocation of Partnership and Matching Shares under Inland Revenue ApprovedShare Incentive Plan 7) Number of shares/amount of stock acquired642 (consisting of 321 Partnership and 321 Matching Shares) 8) Percentage of issued class0.0012% 9) Number of shares/amount of stock disposedNil 10) Percentage of issued classNil 11) Class of securityOrdinary 10 pence shares 12) Price per share£4.67 13) Date of transaction3 February 2005 14) Date company informed3 February 2005 15) Total holding following this notification22,549 16) Total percentage holding of issued class following this notification0.043% If a director has been granted options by the company please complete thefollowing boxes 17) Date of grant 18) Period during which or date on which exercisable 19) Total amount paid (if any) for grant of the option 20) Description of shares or debentures involved: class, number 21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 22) Total number of shares or debentures over which options held following this notification 23) Any additional informationThis transaction is exempt pursuant to provision 20H of the Model Code of theListing Rules of the UK Listing Authority 24) Name of contact and telephone number for queriesJustin Hoskins : 01223 898589 25) Name and signature of authorised company official responsible for making this notificationDiane Mellett Date of Notification 3 February 2005 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) Name of companyCambridge Antibody Technology 2) Name of directorDavid Glover 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of anon-beneficial interest or in the case of an individual holder if it is aholding of that person's spouse or children under the age of 18 or in respect ofa non-beneficial interestAs in 2 Above 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified)Computershare Trustees Limited 5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s)As in 2 Above 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionaryAllocation of Partnership and Matching Shares under Inland Revenue ApprovedShare Incentive Plan 7) Number of shares/amount of stock acquired642 (consisting of 321 Partnership and 321 Matching Shares) 8) Percentage of issued class0.0012% 9) Number of shares/amount of stock disposedNil 10) Percentage of issued classNil 11) Class of securityOrdinary 10 pence shares 12) Price per share£4.67 13) Date of transaction3 February 2005 14) Date company informed3 February 2005 15) Total holding following this notification29,372 16) Total percentage holding of issued class following this notification0.057% If a director has been granted options by the company please complete thefollowing boxes 17) Date of grant 18) Period during which or date on which exercisable 19) Total amount paid (if any) for grant of the option 20) Description of shares or debentures involved: class, number 21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 22) Total number of shares or debentures over which options held following this notification 23) Any additional informationThis transaction is exempt pursuant to provision 20H of the Model Code of theListing Rules of the UK Listing Authority 24) Name of contact and telephone number for queriesJustin Hoskins : 01223 898589 25) Name and signature of authorised company official responsible for making this notificationDiane Mellett Date of Notification 3 February 2005 This information is provided by RNS The company news service from the London Stock Exchange